Have a personal or library account? Click to login

FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: comparison with MRI

Open Access
|Nov 2022

Authors

Milica Stojiljkovic

milica_stoji@yahoo.com

Center for Nuclear Medicine with PET, University Clinical Center of Serbia, Belgrade, Serbia
Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Dragana Sobic Saranovic

Center for Nuclear Medicine with PET, University Clinical Center of Serbia, Belgrade, Serbia
Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Strahinja Odalovic

Center for Nuclear Medicine with PET, University Clinical Center of Serbia, Belgrade, Serbia
Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Marina Popovic

Institute of Oncology and Radiology of Serbia, Belgrade, Serbia

Jelena Petrovic

Center for Nuclear Medicine with PET, University Clinical Center of Serbia, Belgrade, Serbia
Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Nevena Rankovic

Center for Nuclear Medicine with PET, University Clinical Center of Serbia, Belgrade, Serbia

Milos Veljkovic

Center for Nuclear Medicine with PET, University Clinical Center of Serbia, Belgrade, Serbia

Vera Artiko

Center for Nuclear Medicine with PET, University Clinical Center of Serbia, Belgrade, Serbia
Faculty of Medicine, University of Belgrade, Belgrade, Serbia
DOI: https://doi.org/10.2478/raon-2022-0042 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 453 - 460
Submitted on: Apr 18, 2022
Accepted on: Sep 15, 2022
Published on: Nov 2, 2022
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Milica Stojiljkovic, Dragana Sobic Saranovic, Strahinja Odalovic, Marina Popovic, Jelena Petrovic, Nevena Rankovic, Milos Veljkovic, Vera Artiko, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.